Recombinant DNA Technology Market

Recombinant DNA Technology Market - Trends,
Opportunity And Analysis 2025
Recombinant DNA (rDNA) technology is a novel technique which have led to the advances in a
number of different fields such as drug development, agriculture and research. Recombinant
DNA technology has introduced new classes of organism namely genetically modified organism
(GMO) or living modified organism (LMO). It can develop genetically modified crops (BT
cotton), cloned animals, bio pesticides, biofuel, and gene therapy successfully. rDNA technology
has triggered the biopharmaceutical industries towards the development of various rDNA
products such as CAR-T cell therapy and bispecific and monoclonal antibodies in turn favoring
the growth of recombinant DNA technology market. Also, the gene editing system CRISPR holds
a great potential for the development of vaccines and drugs, as they play a major role in
stability and enhancement of immunity.
Get Sample Copy At:
The global recombinant DNA technology market was valued at US$ 106.8 billion in 2017, and
is expected to exhibit a robust CAGR of 7.9% over the forecast period (2017 – 2025).
Report includes chapters which deeply display the following deliverable about industry :
• Recombinant DNA Technology Market Research Objective and Assumption
• Recombinant DNA Technology Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Recombinant DNA Technology Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Recombinant DNA Technology Market, By Regions
• Recombinant DNA Technology Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Recombinant DNA Technology Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Recombinant DNA Technology Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Recombinant DNA Technology Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Increasing technological advancements facilitating the production of novel products is expected
to drive growth of the market
The tremendous advancements combined with wide range of applications to treat life
threatening human diseases such as cancer, diabetes and infectious diseases are expected to be
the major factors augmenting the market growth. According to the Global Diabetes Community,
2017, an estimated 422 million adults are suffering from diabetes worldwide, where the number
is expected to escalate to 642 million by 2040. Also, according to the World Health
Organization (WHO), an estimated 1.5 million deaths were directly caused by diabetes and
another 2.2 million deaths were attributable to hyperglycemia or high blood glucose levels.
Advancement in recombinant technologies have facilitated the development of long-acting
therapeutic proteins for drug development as well as introduced gene therapy, which is a novel
molecular medicine, thus supporting the growth of recombinant DNA technology market by
creating a positive impact in the treatment of genetic diseases. Moreover, the novel gene editing
tool- CRISPR, can be used to target destruction of abnormal genes in human cells and has
provided scientists a powerful way to make precise changes to DNA of microbes, plants, mice,
dogs and human cells.
To Get Instant Access, Purchase Report Here @
Market Dynamics
Rapid technological advancements in the field of genetic engineering to deliver highly efficient
therapeutics for disease management and in the field of agriculture are major driving factors for
growth of recombinant DNA technology market. For instance, Bac-to-Bac Baculovirus Expression
Systems offers a quick and efficient method to produce recombinant baculovirus and can express
the desired genes in insect cells and provide high yields of recombinant protein that speeds up
the cloning reaction as compared to the time-consuming restriction enzyme cloning, which takes
2–3 days. Also, in 2016, a BioAg Alliance was formed between Monsanto and Novozymes A/S,
to improve crop harvests by using products containing naturally-occurring microbes to boost
agricultural productivity and expand its product portfolio. However, the adoption of nonbiologic therapeutics and higher complexity of the genetically engineered products such as
stability of the cell lines, requirement of skilled professionals, and optimum temperature are the
factors hindering the market growth.
Major players operating in the global recombinant DNA technology market are Thermo Fisher
Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen,
Inc., and Monsanto Company.
Browse Complete Report For More Information @
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Recombinant DNA (rDNA) technology is a novel technique which have led to the advances in a number of different fields such as drug development, agriculture and research.